A cyclopropanecarboxamide serotonin and norepinephrine reuptake inhibitor (SNRI) that is used in the treatment of FIBROMYALGIA.
Milnacipran Hydrochloride has been studied across 3 research domains including 🌤️ Mood & Depression, 💊 Pain, ❤️ Cardiovascular. The primary research focus is 🌤️ Mood & Depression with 60% of studies addressing this area.
This evidence profile for Milnacipran Hydrochloride is generated deterministically from 5 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.